Dr. Reddy's: Needs To Invest $0.95 To Produce $1 Of New Revenues
2025-08-04 06:10:00 ET
Investment Summary
Dr. Reddy’s Laboratories ( RDY ) entered FY '26 well positioned and posted reasonable Q1 FY'26 numbers in July. Since my last publication, the stock has been heavily sold and remains in a cyclical downtrend on the combo of 1) macro headwinds, 2) capital intensity, and 3) lower turnover on invested capital in the business. This has offset the marginal gains its sales used to produce, meaning returns on capital have crimped, and the business now, on my numbers, invests up to $0.95 to produce $1 of new sales, thus lowering corporate value as more freely available cash flow is tied up into sustaining its current level of earnings....
Read the full article on Seeking Alpha
For further details see:
Dr. Reddy's: Needs To Invest $0.95 To Produce $1 Of New Revenues
NASDAQ: RDY
RDY Trading
-1.24% G/L:
$13.935 Last:
1,500,046 Volume:
$14.11 Open:
